Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Leiyunshang Pharmaceutical (formerly Yunnan Leiyunshang Ideal Pharmaceutical) is a Chinese pharmaceutical company specializing in the research, development, manufacture, and commercialization of traditional Chinese medicines (TCM) and chemical drugs, with a strong focus on renal and urological health. Founded in 1996 and based in Kunming, Yunnan, the company became part of the Leiyunshang Pharmaceutical Group (under China Grand Enterprises) in 2016. Its flagship products include Shenshuaining Capsule (肾衰宁胶囊) for chronic kidney disease and chronic renal failure, and Xuenuan Capsule (血尿安胶囊) for urinary tract infections and hematuria. The company operates modern GMP-certified manufacturing facilities and collaborates with academic institutions to advance modern TCM therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Leiyunshang Ideal Pharmaceutical.